AbbVie EBIT 2010-2024 | ABBV

AbbVie EBIT for the quarter ending September 30, 2024 was $3.831B, a 67.95% increase year-over-year.

  • AbbVie 2023 EBIT was 12.757B, a 29.59% decline from 2022.
  • AbbVie 2022 EBIT was 18.117B, a 1.08% increase from 2021.
  • AbbVie 2021 EBIT was 17.924B, a 57.74% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

AbbVie EBIT 2010-2024 | ABBV

  • AbbVie 2023 EBIT was 12.757B, a 29.59% decline from 2022.
  • AbbVie 2022 EBIT was 18.117B, a 1.08% increase from 2021.
  • AbbVie 2021 EBIT was 17.924B, a 57.74% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B